Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholestasis | 60 | 2023 | 226 | 13.470 |
Why?
|
Biliary Atresia | 58 | 2024 | 197 | 9.180 |
Why?
|
Liver Diseases | 44 | 2022 | 273 | 8.480 |
Why?
|
Parenteral Nutrition | 17 | 2023 | 95 | 6.280 |
Why?
|
Liver | 62 | 2023 | 1744 | 4.020 |
Why?
|
Bile Acids and Salts | 24 | 2023 | 177 | 3.720 |
Why?
|
Hypertension, Portal | 15 | 2023 | 62 | 3.430 |
Why?
|
Vitamin E | 50 | 2016 | 111 | 3.170 |
Why?
|
Alagille Syndrome | 13 | 2024 | 36 | 2.850 |
Why?
|
Vitamin E Deficiency | 36 | 2016 | 42 | 2.690 |
Why?
|
Hepatopulmonary Syndrome | 6 | 2018 | 25 | 2.680 |
Why?
|
Bilirubin | 24 | 2023 | 93 | 2.640 |
Why?
|
Liver Transplantation | 41 | 2023 | 830 | 2.580 |
Why?
|
Mitochondria, Liver | 19 | 2013 | 69 | 2.530 |
Why?
|
Intestinal Diseases | 5 | 2021 | 30 | 2.500 |
Why?
|
Cholestasis, Intrahepatic | 15 | 2023 | 40 | 2.480 |
Why?
|
Hepatocytes | 13 | 2023 | 204 | 2.190 |
Why?
|
Phytosterols | 3 | 2023 | 11 | 2.170 |
Why?
|
Antioxidants | 16 | 2023 | 554 | 2.070 |
Why?
|
Liver Failure, Acute | 10 | 2023 | 60 | 1.990 |
Why?
|
Infant | 128 | 2023 | 8121 | 1.940 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 4 | 2023 | 196 | 1.760 |
Why?
|
Portoenterostomy, Hepatic | 18 | 2023 | 54 | 1.760 |
Why?
|
Mitochondrial Diseases | 8 | 2024 | 79 | 1.680 |
Why?
|
Infant, Newborn | 71 | 2023 | 5170 | 1.640 |
Why?
|
Neonatal Screening | 12 | 2019 | 149 | 1.590 |
Why?
|
Fat Emulsions, Intravenous | 3 | 2020 | 30 | 1.590 |
Why?
|
Child | 131 | 2024 | 18876 | 1.440 |
Why?
|
Infant, Newborn, Diseases | 3 | 2021 | 106 | 1.420 |
Why?
|
Lipoproteins | 6 | 2023 | 164 | 1.330 |
Why?
|
Humans | 271 | 2024 | 117047 | 1.320 |
Why?
|
Hypertension, Pulmonary | 9 | 2018 | 1771 | 1.310 |
Why?
|
Kupffer Cells | 6 | 2023 | 47 | 1.270 |
Why?
|
NF-kappa B | 3 | 2023 | 639 | 1.250 |
Why?
|
Glycochenodeoxycholic Acid | 9 | 2008 | 12 | 1.230 |
Why?
|
Non-alcoholic Fatty Liver Disease | 7 | 2024 | 279 | 1.220 |
Why?
|
Cystic Fibrosis | 20 | 2016 | 977 | 1.190 |
Why?
|
Gastroenterology | 5 | 2016 | 159 | 1.090 |
Why?
|
Fatty Liver | 7 | 2020 | 246 | 1.040 |
Why?
|
Child, Preschool | 93 | 2022 | 9322 | 0.990 |
Why?
|
Male | 150 | 2023 | 56660 | 0.950 |
Why?
|
Animals | 62 | 2023 | 32736 | 0.930 |
Why?
|
Liver Cirrhosis | 11 | 2023 | 245 | 0.920 |
Why?
|
Bile Ducts | 10 | 2014 | 77 | 0.900 |
Why?
|
Phosphatidylcholines | 1 | 2023 | 132 | 0.870 |
Why?
|
Cholagogues and Choleretics | 2 | 2019 | 10 | 0.840 |
Why?
|
Abdominal Injuries | 1 | 2023 | 98 | 0.840 |
Why?
|
Mice | 20 | 2023 | 15308 | 0.840 |
Why?
|
Intestines | 4 | 2015 | 326 | 0.830 |
Why?
|
Oxidative Stress | 12 | 2018 | 1148 | 0.820 |
Why?
|
Cholangitis, Sclerosing | 1 | 2023 | 74 | 0.820 |
Why?
|
Isoxazoles | 1 | 2021 | 55 | 0.790 |
Why?
|
Digestive System Surgical Procedures | 2 | 2019 | 89 | 0.780 |
Why?
|
Short Bowel Syndrome | 2 | 2020 | 19 | 0.750 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 1136 | 0.740 |
Why?
|
Dietary Supplements | 7 | 2022 | 466 | 0.700 |
Why?
|
Interleukin-1beta | 2 | 2021 | 368 | 0.700 |
Why?
|
Interleukin-6 | 2 | 2023 | 673 | 0.690 |
Why?
|
Copper | 11 | 1998 | 99 | 0.680 |
Why?
|
Research | 6 | 2007 | 402 | 0.680 |
Why?
|
Nutritional Support | 1 | 2019 | 27 | 0.680 |
Why?
|
Bile | 2 | 2016 | 27 | 0.660 |
Why?
|
Disease Models, Animal | 13 | 2023 | 3648 | 0.660 |
Why?
|
Female | 131 | 2023 | 60630 | 0.660 |
Why?
|
RNA, Messenger | 7 | 2023 | 2632 | 0.650 |
Why?
|
Macrophages | 6 | 2021 | 1297 | 0.640 |
Why?
|
Hypoxia | 5 | 2018 | 950 | 0.640 |
Why?
|
Gastrointestinal Diseases | 5 | 2007 | 186 | 0.640 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 93 | 0.630 |
Why?
|
Adolescent | 68 | 2022 | 18213 | 0.630 |
Why?
|
Macrophage Activation | 5 | 2023 | 164 | 0.630 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 30 | 0.630 |
Why?
|
Apoptosis | 10 | 2007 | 2433 | 0.620 |
Why?
|
Reactive Oxygen Species | 8 | 2005 | 566 | 0.610 |
Why?
|
Gene Expression | 3 | 2021 | 1466 | 0.600 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2018 | 58 | 0.600 |
Why?
|
Rats | 28 | 2011 | 5172 | 0.590 |
Why?
|
Hepatitis, Viral, Human | 4 | 2012 | 25 | 0.570 |
Why?
|
Lipid Peroxidation | 11 | 1998 | 150 | 0.570 |
Why?
|
DNA, Mitochondrial | 7 | 2023 | 185 | 0.570 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2018 | 237 | 0.570 |
Why?
|
Vitamin A Deficiency | 4 | 2005 | 26 | 0.560 |
Why?
|
Liver Failure | 6 | 2011 | 84 | 0.560 |
Why?
|
alpha 1-Antitrypsin Deficiency | 4 | 2023 | 78 | 0.540 |
Why?
|
Hepatitis B | 3 | 2009 | 52 | 0.530 |
Why?
|
Sarcopenia | 3 | 2023 | 71 | 0.530 |
Why?
|
End Stage Liver Disease | 1 | 2017 | 75 | 0.520 |
Why?
|
Severity of Illness Index | 10 | 2022 | 2633 | 0.520 |
Why?
|
Cytomegalovirus Infections | 4 | 2024 | 182 | 0.510 |
Why?
|
Nervous System Diseases | 10 | 2001 | 254 | 0.500 |
Why?
|
Vitamins | 7 | 2022 | 156 | 0.490 |
Why?
|
Preoperative Care | 1 | 2017 | 324 | 0.490 |
Why?
|
alpha-Tocopherol | 4 | 2012 | 23 | 0.480 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2014 | 6 | 0.480 |
Why?
|
Mitochondria | 9 | 2013 | 775 | 0.480 |
Why?
|
Nutritional Status | 10 | 2021 | 296 | 0.460 |
Why?
|
Health Status | 5 | 2015 | 726 | 0.450 |
Why?
|
Pruritus | 5 | 2023 | 60 | 0.450 |
Why?
|
Mitochondrial Membrane Transport Proteins | 3 | 2008 | 31 | 0.440 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2010 | 18 | 0.440 |
Why?
|
Toll-Like Receptor 4 | 2 | 2013 | 293 | 0.440 |
Why?
|
Prospective Studies | 26 | 2022 | 6389 | 0.420 |
Why?
|
Vitamin D | 6 | 2014 | 345 | 0.420 |
Why?
|
Vitamin A | 6 | 2014 | 53 | 0.410 |
Why?
|
Metabolism, Inborn Errors | 4 | 2008 | 38 | 0.410 |
Why?
|
Elasticity Imaging Techniques | 2 | 2022 | 44 | 0.410 |
Why?
|
Pediatrics | 5 | 2013 | 979 | 0.410 |
Why?
|
Prognosis | 14 | 2023 | 3390 | 0.410 |
Why?
|
Immunity, Humoral | 1 | 2013 | 115 | 0.410 |
Why?
|
Rare Diseases | 3 | 2022 | 91 | 0.410 |
Why?
|
Quality of Life | 8 | 2023 | 2374 | 0.410 |
Why?
|
Intestinal Absorption | 7 | 1994 | 100 | 0.400 |
Why?
|
Gastrointestinal Microbiome | 2 | 2015 | 534 | 0.400 |
Why?
|
Treatment Outcome | 26 | 2023 | 9256 | 0.400 |
Why?
|
Aspartate Aminotransferases | 8 | 2022 | 92 | 0.400 |
Why?
|
Parenteral Nutrition, Total | 6 | 2004 | 38 | 0.400 |
Why?
|
Mutation | 13 | 2021 | 3420 | 0.390 |
Why?
|
Abnormalities, Multiple | 6 | 2019 | 178 | 0.390 |
Why?
|
Rats, Sprague-Dawley | 15 | 2006 | 2321 | 0.390 |
Why?
|
gamma-Glutamyltransferase | 6 | 2020 | 42 | 0.390 |
Why?
|
Glutathione | 6 | 2006 | 314 | 0.390 |
Why?
|
Microsomes, Liver | 4 | 2004 | 61 | 0.380 |
Why?
|
RNA, Small Interfering | 2 | 2023 | 561 | 0.380 |
Why?
|
Ubiquinone | 3 | 2008 | 22 | 0.380 |
Why?
|
Prevalence | 11 | 2020 | 2300 | 0.370 |
Why?
|
Alanine Transaminase | 8 | 2016 | 146 | 0.370 |
Why?
|
Biomarkers | 15 | 2024 | 3549 | 0.370 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2021 | 36 | 0.360 |
Why?
|
F2-Isoprostanes | 3 | 2018 | 17 | 0.360 |
Why?
|
Microbiota | 2 | 2014 | 662 | 0.360 |
Why?
|
Natriuretic Peptides | 1 | 2009 | 8 | 0.360 |
Why?
|
Cell Membrane Permeability | 3 | 2012 | 87 | 0.350 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 4839 | 0.350 |
Why?
|
Chronic Disease | 16 | 2018 | 1619 | 0.350 |
Why?
|
Hepatolenticular Degeneration | 4 | 1996 | 16 | 0.350 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 2408 | 0.350 |
Why?
|
Survival Rate | 11 | 2017 | 1679 | 0.350 |
Why?
|
Vitamin D Deficiency | 4 | 2011 | 159 | 0.350 |
Why?
|
Immunoglobulins, Intravenous | 4 | 2019 | 125 | 0.340 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 10 | 0.340 |
Why?
|
Cohort Studies | 14 | 2022 | 5050 | 0.340 |
Why?
|
Roseolovirus Infections | 1 | 2009 | 6 | 0.340 |
Why?
|
Aldehydes | 2 | 2022 | 148 | 0.330 |
Why?
|
Cytochromes c | 5 | 2008 | 62 | 0.330 |
Why?
|
Agammaglobulinemia | 1 | 2009 | 31 | 0.330 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2010 | 125 | 0.330 |
Why?
|
Glycyrrhetinic Acid | 2 | 2006 | 7 | 0.330 |
Why?
|
Signal Transduction | 6 | 2023 | 4606 | 0.320 |
Why?
|
Time Factors | 17 | 2018 | 6240 | 0.320 |
Why?
|
Mitochondrial Membranes | 1 | 2008 | 34 | 0.320 |
Why?
|
Hirschsprung Disease | 1 | 2010 | 89 | 0.320 |
Why?
|
Adenosine Triphosphate | 3 | 2023 | 436 | 0.310 |
Why?
|
Malabsorption Syndromes | 5 | 2020 | 14 | 0.310 |
Why?
|
Survivors | 5 | 2014 | 408 | 0.300 |
Why?
|
Intussusception | 1 | 2007 | 27 | 0.300 |
Why?
|
Autoantibodies | 7 | 2006 | 1332 | 0.300 |
Why?
|
beta Carotene | 4 | 2007 | 17 | 0.300 |
Why?
|
Colonic Diseases | 1 | 2007 | 25 | 0.300 |
Why?
|
Genes, Mitochondrial | 1 | 2007 | 14 | 0.300 |
Why?
|
Taurochenodeoxycholic Acid | 4 | 2005 | 7 | 0.300 |
Why?
|
Membrane Proteins | 4 | 2019 | 1040 | 0.300 |
Why?
|
Inflammation | 7 | 2023 | 2515 | 0.300 |
Why?
|
Immunity, Innate | 1 | 2013 | 742 | 0.290 |
Why?
|
Hepatitis | 4 | 2020 | 46 | 0.290 |
Why?
|
Antiviral Agents | 3 | 2009 | 655 | 0.290 |
Why?
|
Abdomen, Acute | 1 | 2006 | 17 | 0.290 |
Why?
|
Bile Duct Diseases | 1 | 2006 | 17 | 0.290 |
Why?
|
Follow-Up Studies | 14 | 2021 | 4507 | 0.280 |
Why?
|
Anastomosis, Roux-en-Y | 2 | 2011 | 30 | 0.280 |
Why?
|
Colonic Polyps | 1 | 2007 | 73 | 0.280 |
Why?
|
Influenza A virus | 1 | 2006 | 90 | 0.270 |
Why?
|
Necrosis | 6 | 2005 | 223 | 0.270 |
Why?
|
Chemical and Drug Induced Liver Injury | 2 | 1998 | 134 | 0.270 |
Why?
|
Growth Disorders | 3 | 2018 | 83 | 0.260 |
Why?
|
Child Welfare | 3 | 2020 | 198 | 0.260 |
Why?
|
Galactose | 2 | 2003 | 20 | 0.260 |
Why?
|
Prothrombin Time | 5 | 2012 | 34 | 0.260 |
Why?
|
Glycyrrhizic Acid | 1 | 2005 | 3 | 0.260 |
Why?
|
Glycyrrhiza | 1 | 2005 | 2 | 0.260 |
Why?
|
Caspases | 3 | 2018 | 259 | 0.250 |
Why?
|
Enzyme Inhibitors | 4 | 2005 | 775 | 0.250 |
Why?
|
Biliary Tract Surgical Procedures | 2 | 2011 | 25 | 0.250 |
Why?
|
Interferon-alpha | 3 | 2009 | 191 | 0.250 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2021 | 129 | 0.250 |
Why?
|
Oxidants | 2 | 1996 | 117 | 0.250 |
Why?
|
Ion Channels | 2 | 2005 | 125 | 0.250 |
Why?
|
Diagnosis, Differential | 6 | 2017 | 1341 | 0.250 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 176 | 0.250 |
Why?
|
Cyclosporine | 2 | 2005 | 172 | 0.240 |
Why?
|
Retrospective Studies | 17 | 2023 | 12823 | 0.240 |
Why?
|
Autoimmunity | 5 | 2013 | 829 | 0.240 |
Why?
|
Esophageal and Gastric Varices | 2 | 2022 | 35 | 0.240 |
Why?
|
Celiac Disease | 5 | 2006 | 265 | 0.240 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2012 | 107 | 0.240 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 957 | 0.240 |
Why?
|
Facies | 1 | 2004 | 21 | 0.240 |
Why?
|
Ursodeoxycholic Acid | 3 | 2015 | 22 | 0.230 |
Why?
|
Phenotype | 9 | 2023 | 2891 | 0.230 |
Why?
|
Avitaminosis | 2 | 2014 | 7 | 0.230 |
Why?
|
Fetal Diseases | 1 | 2005 | 148 | 0.230 |
Why?
|
Metabolic Diseases | 2 | 2014 | 102 | 0.230 |
Why?
|
Erythrocytes | 4 | 2001 | 604 | 0.230 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2024 | 35 | 0.230 |
Why?
|
Genes, Regulator | 1 | 2023 | 33 | 0.230 |
Why?
|
Immunoglobulin G | 2 | 2014 | 786 | 0.230 |
Why?
|
Waiting Lists | 3 | 2017 | 225 | 0.230 |
Why?
|
ARNTL Transcription Factors | 1 | 2023 | 16 | 0.230 |
Why?
|
alpha 1-Antitrypsin | 3 | 2023 | 109 | 0.220 |
Why?
|
Glucocorticoids | 1 | 2007 | 544 | 0.220 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2023 | 8 | 0.220 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 57 | 0.220 |
Why?
|
Enterohepatic Circulation | 2 | 2017 | 7 | 0.220 |
Why?
|
Serum Albumin | 5 | 2012 | 140 | 0.220 |
Why?
|
Lipids | 10 | 2013 | 584 | 0.220 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 508 | 0.220 |
Why?
|
Early Diagnosis | 2 | 2019 | 221 | 0.220 |
Why?
|
Biliary Tract Diseases | 2 | 2002 | 34 | 0.220 |
Why?
|
Sterols | 2 | 2021 | 17 | 0.220 |
Why?
|
Adult | 40 | 2022 | 31003 | 0.210 |
Why?
|
Europe | 4 | 2016 | 349 | 0.210 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2012 | 17 | 0.210 |
Why?
|
Abdominal Pain | 2 | 2007 | 132 | 0.210 |
Why?
|
Varicose Veins | 1 | 2022 | 15 | 0.210 |
Why?
|
United States | 20 | 2020 | 12379 | 0.210 |
Why?
|
Benzimidazoles | 1 | 2023 | 138 | 0.210 |
Why?
|
Transplantation Immunology | 1 | 2011 | 31 | 0.200 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2016 | 289 | 0.200 |
Why?
|
Jaundice, Neonatal | 3 | 1987 | 8 | 0.200 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 147 | 0.200 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 76 | 0.200 |
Why?
|
Hepatic Encephalopathy | 2 | 1998 | 21 | 0.200 |
Why?
|
Reference Values | 6 | 2018 | 750 | 0.200 |
Why?
|
Hep G2 Cells | 1 | 2021 | 72 | 0.200 |
Why?
|
Lung | 3 | 2012 | 3588 | 0.200 |
Why?
|
Feces | 2 | 2015 | 386 | 0.200 |
Why?
|
Infliximab | 1 | 2021 | 94 | 0.200 |
Why?
|
Bongkrekic Acid | 1 | 2001 | 2 | 0.200 |
Why?
|
Pilot Projects | 6 | 2018 | 1394 | 0.190 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2021 | 134 | 0.190 |
Why?
|
Biopsy | 12 | 2017 | 1056 | 0.190 |
Why?
|
Anemia, Hemolytic | 1 | 2001 | 19 | 0.190 |
Why?
|
Longitudinal Studies | 9 | 2021 | 2480 | 0.190 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2013 | 291 | 0.190 |
Why?
|
Risk Factors | 10 | 2020 | 8873 | 0.190 |
Why?
|
Influenza, Human | 2 | 2006 | 551 | 0.190 |
Why?
|
Malnutrition | 1 | 2021 | 66 | 0.190 |
Why?
|
Vitamin K | 4 | 2014 | 42 | 0.190 |
Why?
|
Fontan Procedure | 1 | 2003 | 151 | 0.190 |
Why?
|
Hepatoblastoma | 1 | 2000 | 25 | 0.180 |
Why?
|
Age Factors | 8 | 2017 | 2950 | 0.180 |
Why?
|
Creativity | 1 | 2020 | 8 | 0.180 |
Why?
|
Adenosine Triphosphatases | 1 | 2021 | 157 | 0.180 |
Why?
|
Cytochrome-c Oxidase Deficiency | 1 | 2020 | 2 | 0.180 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 310 | 0.180 |
Why?
|
Soybean Oil | 1 | 2020 | 12 | 0.180 |
Why?
|
Tandem Mass Spectrometry | 1 | 2022 | 418 | 0.180 |
Why?
|
Survival Analysis | 7 | 2021 | 1240 | 0.180 |
Why?
|
Intersectoral Collaboration | 1 | 2020 | 56 | 0.180 |
Why?
|
Peripheral Nervous System Diseases | 4 | 1990 | 121 | 0.180 |
Why?
|
Emulsions | 2 | 2013 | 44 | 0.180 |
Why?
|
Patient Care Management | 1 | 2020 | 55 | 0.180 |
Why?
|
Liver Function Tests | 8 | 2016 | 106 | 0.170 |
Why?
|
Colitis, Ulcerative | 3 | 2010 | 105 | 0.170 |
Why?
|
Hydrogen Peroxide | 2 | 2005 | 296 | 0.170 |
Why?
|
Immunoblotting | 4 | 2014 | 292 | 0.170 |
Why?
|
Registries | 6 | 2017 | 1788 | 0.170 |
Why?
|
Outpatients | 1 | 2022 | 327 | 0.170 |
Why?
|
Ascites | 2 | 2015 | 36 | 0.170 |
Why?
|
Fibroblasts | 3 | 2014 | 839 | 0.170 |
Why?
|
Hypersplenism | 1 | 1998 | 6 | 0.170 |
Why?
|
Societies, Medical | 3 | 2016 | 684 | 0.170 |
Why?
|
Autophagy | 1 | 2022 | 308 | 0.170 |
Why?
|
Rotavirus Infections | 3 | 2006 | 54 | 0.160 |
Why?
|
Oxypurinol | 1 | 1998 | 1 | 0.160 |
Why?
|
Syndrome | 6 | 2019 | 339 | 0.160 |
Why?
|
Disease Progression | 4 | 2020 | 2467 | 0.160 |
Why?
|
Zinc | 2 | 1999 | 260 | 0.160 |
Why?
|
Failure to Thrive | 1 | 2018 | 32 | 0.160 |
Why?
|
Vertebrates | 1 | 1999 | 59 | 0.160 |
Why?
|
Dystroglycans | 1 | 2018 | 7 | 0.160 |
Why?
|
Qb-SNARE Proteins | 1 | 2018 | 6 | 0.160 |
Why?
|
Polyethylene Glycols | 8 | 2012 | 574 | 0.160 |
Why?
|
Research Design | 2 | 2016 | 962 | 0.160 |
Why?
|
Polycystic Kidney Diseases | 1 | 2019 | 55 | 0.160 |
Why?
|
Caspases, Initiator | 1 | 2018 | 18 | 0.160 |
Why?
|
Liver X Receptors | 1 | 2018 | 30 | 0.160 |
Why?
|
Xanthine Oxidase | 1 | 1998 | 80 | 0.160 |
Why?
|
North America | 5 | 2016 | 268 | 0.160 |
Why?
|
Cytomegalovirus | 2 | 2023 | 145 | 0.160 |
Why?
|
Safety | 1 | 2020 | 298 | 0.160 |
Why?
|
Benzoquinones | 1 | 1998 | 43 | 0.160 |
Why?
|
Calcifediol | 2 | 2011 | 29 | 0.160 |
Why?
|
Muscular Dystrophies | 1 | 2018 | 36 | 0.160 |
Why?
|
Immunohistochemistry | 4 | 2014 | 1657 | 0.160 |
Why?
|
Premature Birth | 1 | 2021 | 276 | 0.160 |
Why?
|
Morphogenesis | 1 | 1999 | 165 | 0.160 |
Why?
|
Herpesvirus 4, Human | 1 | 1998 | 123 | 0.160 |
Why?
|
Neurodevelopmental Disorders | 1 | 2020 | 119 | 0.160 |
Why?
|
Intestine, Small | 3 | 2005 | 129 | 0.150 |
Why?
|
Fructose | 2 | 2022 | 195 | 0.150 |
Why?
|
Cross-Sectional Studies | 7 | 2013 | 4510 | 0.150 |
Why?
|
Epigenesis, Genetic | 2 | 2013 | 546 | 0.150 |
Why?
|
Injections, Subcutaneous | 3 | 2007 | 137 | 0.150 |
Why?
|
Fibrosis | 3 | 2014 | 478 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 1998 | 71 | 0.150 |
Why?
|
Oximetry | 1 | 2018 | 80 | 0.150 |
Why?
|
Virus Diseases | 3 | 2013 | 201 | 0.150 |
Why?
|
Caspase 1 | 1 | 2018 | 142 | 0.150 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 82 | 0.150 |
Why?
|
Indians, North American | 2 | 2001 | 595 | 0.150 |
Why?
|
Obesity | 3 | 2013 | 2661 | 0.150 |
Why?
|
Spleen | 1 | 2019 | 488 | 0.150 |
Why?
|
Emotional Adjustment | 1 | 2017 | 17 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2005 | 350 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 227 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 255 | 0.140 |
Why?
|
Graft Survival | 3 | 2012 | 487 | 0.140 |
Why?
|
Schools | 1 | 2020 | 403 | 0.140 |
Why?
|
Ammonia | 2 | 2008 | 60 | 0.140 |
Why?
|
Pyruvic Acid | 1 | 2017 | 43 | 0.140 |
Why?
|
Embolization, Therapeutic | 1 | 1998 | 181 | 0.140 |
Why?
|
Nitric Oxide | 1 | 2002 | 861 | 0.140 |
Why?
|
Rats, Zucker | 2 | 2007 | 26 | 0.140 |
Why?
|
History, 21st Century | 2 | 2007 | 167 | 0.140 |
Why?
|
Liver Neoplasms | 1 | 2000 | 523 | 0.140 |
Why?
|
Trans-Activators | 1 | 1999 | 374 | 0.140 |
Why?
|
Family Relations | 1 | 2017 | 84 | 0.140 |
Why?
|
Body Mass Index | 4 | 2018 | 2070 | 0.140 |
Why?
|
Lactic Acid | 2 | 2017 | 274 | 0.140 |
Why?
|
History, 20th Century | 2 | 2007 | 277 | 0.140 |
Why?
|
Hepatitis, Chronic | 1 | 1995 | 5 | 0.140 |
Why?
|
Bile Ducts, Intrahepatic | 4 | 2021 | 50 | 0.130 |
Why?
|
Flow Cytometry | 3 | 2005 | 1063 | 0.130 |
Why?
|
Cell Death | 2 | 2008 | 333 | 0.130 |
Why?
|
Oxidative Phosphorylation | 4 | 2003 | 157 | 0.130 |
Why?
|
Predictive Value of Tests | 6 | 2014 | 1824 | 0.130 |
Why?
|
Cholesterol | 7 | 2015 | 371 | 0.130 |
Why?
|
Incidence | 7 | 2013 | 2377 | 0.130 |
Why?
|
Rotavirus | 4 | 2014 | 26 | 0.130 |
Why?
|
MicroRNAs | 1 | 2021 | 627 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 2227 | 0.130 |
Why?
|
Developmental Disabilities | 1 | 2018 | 240 | 0.130 |
Why?
|
Metals | 1 | 1996 | 110 | 0.130 |
Why?
|
Bone Density | 1 | 2018 | 444 | 0.130 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1995 | 14 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 1995 | 30 | 0.130 |
Why?
|
Skinfold Thickness | 2 | 2012 | 46 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 346 | 0.120 |
Why?
|
Neuromuscular Diseases | 2 | 1989 | 90 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 339 | 0.120 |
Why?
|
Plant Oils | 1 | 2014 | 28 | 0.120 |
Why?
|
Echocardiography | 2 | 2009 | 564 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2016 | 161 | 0.120 |
Why?
|
Free Radicals | 4 | 1998 | 101 | 0.120 |
Why?
|
Biopsy, Needle | 2 | 2012 | 181 | 0.120 |
Why?
|
Zonula Occludens-2 Protein | 1 | 2014 | 2 | 0.120 |
Why?
|
Hydrogen | 1 | 2014 | 61 | 0.120 |
Why?
|
Oxygen Consumption | 3 | 1995 | 575 | 0.120 |
Why?
|
Administration, Oral | 4 | 2014 | 744 | 0.120 |
Why?
|
Mental Health | 1 | 2009 | 565 | 0.120 |
Why?
|
Solutions | 2 | 2013 | 149 | 0.120 |
Why?
|
Prednisolone | 1 | 2014 | 76 | 0.120 |
Why?
|
Portal Vein | 2 | 2010 | 87 | 0.120 |
Why?
|
Stigmasterol | 1 | 2013 | 2 | 0.120 |
Why?
|
Bile Canaliculi | 1 | 2013 | 11 | 0.120 |
Why?
|
Methylprednisolone | 1 | 2014 | 83 | 0.120 |
Why?
|
Oxygen | 2 | 2001 | 828 | 0.120 |
Why?
|
Oxidation-Reduction | 3 | 2008 | 910 | 0.120 |
Why?
|
Forms and Records Control | 1 | 2013 | 22 | 0.120 |
Why?
|
Random Allocation | 2 | 2012 | 339 | 0.120 |
Why?
|
Fish Oils | 1 | 2013 | 25 | 0.120 |
Why?
|
Gastritis, Hypertrophic | 1 | 1993 | 3 | 0.120 |
Why?
|
Membrane Potentials | 2 | 2005 | 253 | 0.120 |
Why?
|
Health Policy | 1 | 2017 | 333 | 0.110 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 924 | 0.110 |
Why?
|
Dietary Fats | 3 | 1993 | 305 | 0.110 |
Why?
|
Mass Screening | 3 | 2018 | 1034 | 0.110 |
Why?
|
Tight Junctions | 1 | 2014 | 68 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2005 | 1889 | 0.110 |
Why?
|
Bile Ducts, Extrahepatic | 3 | 2007 | 26 | 0.110 |
Why?
|
Electron Transport Complex IV | 1 | 1993 | 50 | 0.110 |
Why?
|
Caspase 3 | 2 | 2005 | 237 | 0.110 |
Why?
|
Acidosis, Lactic | 1 | 2013 | 29 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 4 | 2022 | 102 | 0.110 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2021 | 124 | 0.110 |
Why?
|
Laparoscopy | 1 | 1997 | 401 | 0.110 |
Why?
|
Autoimmune Diseases | 3 | 2005 | 397 | 0.110 |
Why?
|
Pregnancy | 7 | 2021 | 5653 | 0.110 |
Why?
|
Caspase 9 | 2 | 2005 | 49 | 0.110 |
Why?
|
Prune Belly Syndrome | 1 | 1993 | 7 | 0.110 |
Why?
|
Caspase Inhibitors | 2 | 2005 | 79 | 0.110 |
Why?
|
Thiobarbituric Acid Reactive Substances | 3 | 1998 | 22 | 0.110 |
Why?
|
Pancreatic Elastase | 1 | 2012 | 57 | 0.110 |
Why?
|
Histocytochemistry | 2 | 2011 | 81 | 0.110 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2006 | 110 | 0.110 |
Why?
|
Abetalipoproteinemia | 2 | 1996 | 3 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2013 | 138 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 273 | 0.110 |
Why?
|
Epithelium | 2 | 2006 | 302 | 0.100 |
Why?
|
Nutrition Assessment | 2 | 2004 | 77 | 0.100 |
Why?
|
Nutrition Disorders | 2 | 1998 | 23 | 0.100 |
Why?
|
Case-Control Studies | 7 | 2015 | 3099 | 0.100 |
Why?
|
ROC Curve | 2 | 2015 | 460 | 0.100 |
Why?
|
Serrate-Jagged Proteins | 2 | 2004 | 28 | 0.100 |
Why?
|
Databases, Factual | 4 | 2019 | 1167 | 0.100 |
Why?
|
Cerebral Palsy | 1 | 2013 | 82 | 0.100 |
Why?
|
Pandemics | 1 | 2020 | 1354 | 0.100 |
Why?
|
Financing, Organized | 2 | 2002 | 33 | 0.100 |
Why?
|
Regression Analysis | 4 | 2018 | 971 | 0.100 |
Why?
|
Cyclosporins | 1 | 1991 | 59 | 0.100 |
Why?
|
Risk Assessment | 4 | 2021 | 3021 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 10674 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 173 | 0.100 |
Why?
|
Pedigree | 5 | 2014 | 475 | 0.100 |
Why?
|
Glycogen Storage Disease Type I | 1 | 2010 | 4 | 0.100 |
Why?
|
Diet | 3 | 2011 | 1128 | 0.100 |
Why?
|
Wechsler Scales | 2 | 2022 | 52 | 0.090 |
Why?
|
Anthropometry | 2 | 1992 | 188 | 0.090 |
Why?
|
Double-Blind Method | 4 | 2018 | 1670 | 0.090 |
Why?
|
Retinol-Binding Proteins | 2 | 2012 | 13 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 69 | 0.090 |
Why?
|
Health Services Accessibility | 1 | 2017 | 773 | 0.090 |
Why?
|
Proteins | 3 | 2004 | 930 | 0.090 |
Why?
|
Heterotaxy Syndrome | 1 | 2010 | 10 | 0.090 |
Why?
|
Colorado | 6 | 2013 | 4120 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2008 | 674 | 0.090 |
Why?
|
Steroid Metabolism, Inborn Errors | 1 | 2010 | 1 | 0.090 |
Why?
|
Transglutaminases | 4 | 2006 | 143 | 0.090 |
Why?
|
Global Health | 1 | 2012 | 302 | 0.090 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2010 | 9 | 0.090 |
Why?
|
Rats, Inbred Strains | 4 | 1991 | 377 | 0.090 |
Why?
|
Calcium-Binding Proteins | 2 | 2004 | 211 | 0.090 |
Why?
|
Manganese | 3 | 1998 | 53 | 0.090 |
Why?
|
Adoption | 1 | 1990 | 38 | 0.090 |
Why?
|
Genotype | 2 | 2013 | 1854 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2015 | 525 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2014 | 977 | 0.090 |
Why?
|
Membrane Lipids | 1 | 1990 | 88 | 0.090 |
Why?
|
Erythrocyte Transfusion | 2 | 1989 | 173 | 0.090 |
Why?
|
Animals, Newborn | 4 | 2014 | 797 | 0.090 |
Why?
|
Hemochromatosis | 1 | 2009 | 9 | 0.090 |
Why?
|
Carotenoids | 3 | 2007 | 36 | 0.090 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2009 | 18 | 0.090 |
Why?
|
Electron Transport | 4 | 1999 | 96 | 0.080 |
Why?
|
Chenodeoxycholic Acid | 2 | 2021 | 12 | 0.080 |
Why?
|
Herpesvirus 7, Human | 1 | 2009 | 5 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 2159 | 0.080 |
Why?
|
Galactosemias | 1 | 1989 | 8 | 0.080 |
Why?
|
Blood Transfusion | 2 | 1989 | 251 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2011 | 3361 | 0.080 |
Why?
|
Canada | 4 | 2015 | 337 | 0.080 |
Why?
|
Cell Survival | 4 | 1996 | 1030 | 0.080 |
Why?
|
Nervous System Physiological Phenomena | 1 | 1989 | 22 | 0.080 |
Why?
|
Lamivudine | 1 | 2009 | 59 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2014 | 695 | 0.080 |
Why?
|
Treatment Failure | 1 | 2010 | 337 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2019 | 805 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2008 | 475 | 0.080 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2008 | 18 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 825 | 0.080 |
Why?
|
Organophosphonates | 1 | 2009 | 93 | 0.080 |
Why?
|
Interferon-gamma | 2 | 2014 | 732 | 0.080 |
Why?
|
Tocopherols | 3 | 2005 | 20 | 0.080 |
Why?
|
Cardiolipins | 1 | 2008 | 73 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2006 | 1769 | 0.080 |
Why?
|
Sural Nerve | 3 | 1987 | 19 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 1988 | 467 | 0.080 |
Why?
|
Antibodies, Viral | 2 | 2006 | 532 | 0.080 |
Why?
|
Crohn Disease | 2 | 1997 | 198 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 1403 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2018 | 1458 | 0.080 |
Why?
|
Educational Status | 2 | 2020 | 429 | 0.070 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2007 | 18 | 0.070 |
Why?
|
Selection Bias | 1 | 2007 | 34 | 0.070 |
Why?
|
Texas | 1 | 2007 | 188 | 0.070 |
Why?
|
Adenine | 1 | 2009 | 222 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2009 | 222 | 0.070 |
Why?
|
Rupture, Spontaneous | 1 | 2006 | 17 | 0.070 |
Why?
|
Organizational Policy | 1 | 2007 | 68 | 0.070 |
Why?
|
In Situ Hybridization | 2 | 2005 | 301 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2013 | 809 | 0.070 |
Why?
|
DNA, Viral | 1 | 2009 | 349 | 0.070 |
Why?
|
Th1 Cells | 2 | 2005 | 131 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 91 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2012 | 1993 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 1877 | 0.070 |
Why?
|
Respiratory Insufficiency | 1 | 1990 | 286 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2021 | 2648 | 0.070 |
Why?
|
Executive Function | 1 | 2010 | 372 | 0.070 |
Why?
|
Pulmonary Artery | 2 | 2010 | 1025 | 0.070 |
Why?
|
Radiography | 4 | 1998 | 843 | 0.070 |
Why?
|
Ultrasonography | 3 | 2015 | 671 | 0.070 |
Why?
|
Eating | 2 | 2022 | 363 | 0.070 |
Why?
|
Micronutrients | 1 | 2007 | 78 | 0.070 |
Why?
|
Graft Rejection | 3 | 2011 | 536 | 0.070 |
Why?
|
Drainage | 2 | 2019 | 152 | 0.070 |
Why?
|
Interleukin-8 | 2 | 2022 | 235 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 965 | 0.070 |
Why?
|
Osmolar Concentration | 2 | 2001 | 184 | 0.070 |
Why?
|
Pneumonia | 1 | 2011 | 575 | 0.070 |
Why?
|
Ascorbic Acid | 2 | 1997 | 118 | 0.070 |
Why?
|
Postoperative Complications | 4 | 2019 | 2198 | 0.070 |
Why?
|
Glycoproteins | 2 | 1999 | 317 | 0.070 |
Why?
|
Diterpenes | 1 | 2005 | 31 | 0.070 |
Why?
|
Neutrophils | 1 | 2010 | 1081 | 0.070 |
Why?
|
Enterostomy | 2 | 2014 | 8 | 0.070 |
Why?
|
Risk | 3 | 2018 | 842 | 0.070 |
Why?
|
Immediate-Early Proteins | 1 | 2005 | 52 | 0.070 |
Why?
|
Spectrophotometry | 1 | 2005 | 50 | 0.070 |
Why?
|
Glycogen Storage Disease Type IV | 1 | 2005 | 4 | 0.060 |
Why?
|
1,4-alpha-Glucan Branching Enzyme | 1 | 2005 | 4 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 1740 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2014 | 3956 | 0.060 |
Why?
|
Dry Eye Syndromes | 1 | 2005 | 28 | 0.060 |
Why?
|
Edible Grain | 1 | 2005 | 43 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2011 | 729 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 2005 | 219 | 0.060 |
Why?
|
Caspase 10 | 1 | 2005 | 5 | 0.060 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2005 | 22 | 0.060 |
Why?
|
Glutens | 1 | 2005 | 56 | 0.060 |
Why?
|
Faculty, Medical | 1 | 2007 | 236 | 0.060 |
Why?
|
Child Development | 2 | 2020 | 406 | 0.060 |
Why?
|
Pancrelipase | 2 | 1999 | 6 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2005 | 87 | 0.060 |
Why?
|
Hepatitis B, Chronic | 1 | 2004 | 18 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 965 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 114 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2008 | 392 | 0.060 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 147 | 0.060 |
Why?
|
Jaundice | 2 | 2015 | 14 | 0.060 |
Why?
|
Base Sequence | 7 | 2014 | 2123 | 0.060 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 168 | 0.060 |
Why?
|
Postoperative Care | 2 | 2018 | 226 | 0.060 |
Why?
|
Respiratory Tract Diseases | 1 | 1985 | 141 | 0.060 |
Why?
|
Reoviridae | 2 | 1998 | 37 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 1998 | 1001 | 0.060 |
Why?
|
Granulomatosis with Polyangiitis | 1 | 1984 | 42 | 0.060 |
Why?
|
Sex Distribution | 2 | 2011 | 331 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2007 | 228 | 0.060 |
Why?
|
Retinal Diseases | 1 | 1984 | 79 | 0.060 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2003 | 6 | 0.060 |
Why?
|
Spinal Nerves | 1 | 1983 | 5 | 0.060 |
Why?
|
Reoviridae Infections | 2 | 1998 | 54 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 1996 | 152 | 0.060 |
Why?
|
Weaning | 2 | 1996 | 55 | 0.060 |
Why?
|
Taurocholic Acid | 2 | 1995 | 33 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 2817 | 0.060 |
Why?
|
Cytosol | 1 | 2004 | 206 | 0.060 |
Why?
|
Albumins | 2 | 2014 | 100 | 0.060 |
Why?
|
Infant, Premature, Diseases | 1 | 1984 | 91 | 0.060 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2003 | 195 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2005 | 350 | 0.060 |
Why?
|
Models, Biological | 2 | 2014 | 1689 | 0.060 |
Why?
|
Blood Coagulation Tests | 1 | 2003 | 50 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 404 | 0.050 |
Why?
|
Microscopy, Electron | 3 | 2002 | 412 | 0.050 |
Why?
|
Endoglin | 1 | 2022 | 20 | 0.050 |
Why?
|
Spinal Cord Diseases | 1 | 1983 | 39 | 0.050 |
Why?
|
Facial Expression | 1 | 1983 | 61 | 0.050 |
Why?
|
Anastomosis, Surgical | 2 | 2011 | 141 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 544 | 0.050 |
Why?
|
Remission Induction | 2 | 2010 | 243 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2014 | 376 | 0.050 |
Why?
|
Movement Disorders | 1 | 1983 | 45 | 0.050 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 23 | 0.050 |
Why?
|
Niemann-Pick Diseases | 1 | 2002 | 2 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 456 | 0.050 |
Why?
|
Seasons | 1 | 2005 | 463 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2015 | 1239 | 0.050 |
Why?
|
Quinacrine | 1 | 1982 | 7 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 1183 | 0.050 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2004 | 793 | 0.050 |
Why?
|
Enteral Nutrition | 2 | 2021 | 166 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 761 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 629 | 0.050 |
Why?
|
Ontario | 1 | 2011 | 108 | 0.050 |
Why?
|
Neurologic Examination | 3 | 1988 | 118 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2005 | 572 | 0.050 |
Why?
|
Skin Pigmentation | 1 | 1982 | 44 | 0.050 |
Why?
|
Age of Onset | 2 | 2002 | 456 | 0.050 |
Why?
|
Influenza Vaccines | 1 | 2006 | 499 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2005 | 298 | 0.050 |
Why?
|
International Cooperation | 2 | 2015 | 173 | 0.050 |
Why?
|
Cardiac Catheterization | 1 | 2005 | 528 | 0.050 |
Why?
|
Dietary Carbohydrates | 1 | 2022 | 153 | 0.050 |
Why?
|
Superoxides | 2 | 2010 | 194 | 0.050 |
Why?
|
Codon, Nonsense | 1 | 2021 | 38 | 0.050 |
Why?
|
Colon | 2 | 2010 | 235 | 0.050 |
Why?
|
Biomedical Research | 1 | 2007 | 596 | 0.050 |
Why?
|
Caspase 8 | 1 | 2001 | 47 | 0.050 |
Why?
|
Detergents | 1 | 2001 | 43 | 0.050 |
Why?
|
Ataxia | 2 | 1995 | 36 | 0.050 |
Why?
|
Calpain | 1 | 2001 | 54 | 0.050 |
Why?
|
Hemangioendothelioma | 1 | 2000 | 12 | 0.050 |
Why?
|
Acute Disease | 2 | 1999 | 916 | 0.050 |
Why?
|
Age Distribution | 1 | 2011 | 340 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 222 | 0.050 |
Why?
|
Body Weight | 2 | 2018 | 901 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2001 | 179 | 0.050 |
Why?
|
Fatigue | 1 | 2022 | 288 | 0.050 |
Why?
|
Middle Aged | 9 | 2007 | 27170 | 0.050 |
Why?
|
Glutathione Disulfide | 1 | 2000 | 27 | 0.050 |
Why?
|
Scalp Dermatoses | 1 | 1980 | 2 | 0.050 |
Why?
|
Allostasis | 1 | 2020 | 14 | 0.040 |
Why?
|
Cattle | 2 | 2014 | 957 | 0.040 |
Why?
|
Recombinant Proteins | 3 | 2004 | 1258 | 0.040 |
Why?
|
Haemophilus Infections | 1 | 1980 | 29 | 0.040 |
Why?
|
Cholic Acid | 2 | 1998 | 4 | 0.040 |
Why?
|
Orthomyxoviridae Infections | 1 | 2020 | 53 | 0.040 |
Why?
|
Cellulitis | 1 | 1980 | 46 | 0.040 |
Why?
|
Surveys and Questionnaires | 5 | 2015 | 4661 | 0.040 |
Why?
|
Southwestern United States | 1 | 1999 | 92 | 0.040 |
Why?
|
Hemolysis | 1 | 2001 | 168 | 0.040 |
Why?
|
Social Adjustment | 1 | 2009 | 55 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2002 | 222 | 0.040 |
Why?
|
Rifampin | 1 | 1999 | 68 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 1999 | 60 | 0.040 |
Why?
|
gamma-Globulins | 1 | 1998 | 18 | 0.040 |
Why?
|
Heart | 1 | 2003 | 623 | 0.040 |
Why?
|
Steroid Hydroxylases | 1 | 1998 | 22 | 0.040 |
Why?
|
Pancreatin | 2 | 1991 | 5 | 0.040 |
Why?
|
Cephalometry | 1 | 2018 | 28 | 0.040 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1999 | 51 | 0.040 |
Why?
|
Splenomegaly | 2 | 2012 | 16 | 0.040 |
Why?
|
Colonoscopy | 2 | 2010 | 211 | 0.040 |
Why?
|
Gestational Age | 1 | 2021 | 766 | 0.040 |
Why?
|
Genes | 1 | 1999 | 221 | 0.040 |
Why?
|
Growth | 2 | 2004 | 58 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1998 | 106 | 0.040 |
Why?
|
Succinic Acid | 1 | 1998 | 39 | 0.040 |
Why?
|
Choledochal Cyst | 1 | 1998 | 17 | 0.040 |
Why?
|
Ceruloplasmin | 2 | 1996 | 6 | 0.040 |
Why?
|
Liver Glycogen | 1 | 1998 | 20 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 1999 | 73 | 0.040 |
Why?
|
Hemodynamics | 1 | 2003 | 982 | 0.040 |
Why?
|
Genes, Viral | 1 | 1998 | 89 | 0.040 |
Why?
|
Receptors, Notch | 1 | 1999 | 85 | 0.040 |
Why?
|
In Vitro Techniques | 2 | 2006 | 1049 | 0.040 |
Why?
|
X Chromosome | 1 | 1998 | 46 | 0.040 |
Why?
|
Technetium Tc 99m Disofenin | 1 | 1998 | 3 | 0.040 |
Why?
|
Drug Antagonism | 1 | 1998 | 8 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 741 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2018 | 226 | 0.040 |
Why?
|
Glycogen Storage Disease | 1 | 1998 | 21 | 0.040 |
Why?
|
Glycosylation | 1 | 2018 | 134 | 0.040 |
Why?
|
Postoperative Period | 1 | 1999 | 303 | 0.040 |
Why?
|
Internship and Residency | 1 | 2007 | 964 | 0.040 |
Why?
|
Phosphorylase Kinase | 1 | 1998 | 26 | 0.040 |
Why?
|
Life Style | 1 | 2000 | 432 | 0.040 |
Why?
|
Half-Life | 1 | 1998 | 146 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 86 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 1999 | 174 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2001 | 6453 | 0.040 |
Why?
|
RNA, Viral | 2 | 1998 | 565 | 0.040 |
Why?
|
Observational Studies as Topic | 1 | 2018 | 90 | 0.040 |
Why?
|
Gallbladder | 1 | 2017 | 14 | 0.040 |
Why?
|
Caffeine | 1 | 1998 | 61 | 0.040 |
Why?
|
Motor Skills | 1 | 2018 | 82 | 0.040 |
Why?
|
Placebo Effect | 1 | 1997 | 51 | 0.040 |
Why?
|
Glutathione Peroxidase | 1 | 1997 | 54 | 0.040 |
Why?
|
Genetic Linkage | 1 | 1998 | 311 | 0.040 |
Why?
|
Glucose | 1 | 2022 | 931 | 0.040 |
Why?
|
Creatinine | 1 | 1999 | 481 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2018 | 137 | 0.040 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 1996 | 1 | 0.040 |
Why?
|
Point Mutation | 1 | 1998 | 225 | 0.040 |
Why?
|
Hospital Costs | 1 | 1997 | 107 | 0.040 |
Why?
|
Stereoisomerism | 2 | 1993 | 89 | 0.030 |
Why?
|
Carrier Proteins | 3 | 1996 | 719 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 257 | 0.030 |
Why?
|
Peripheral Nerves | 2 | 1987 | 63 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 1996 | 43 | 0.030 |
Why?
|
Brain | 3 | 2018 | 2381 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 1999 | 456 | 0.030 |
Why?
|
Liver Cirrhosis, Experimental | 1 | 1996 | 11 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2003 | 686 | 0.030 |
Why?
|
Duodenum | 1 | 1996 | 64 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 1998 | 446 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 1271 | 0.030 |
Why?
|
Mesentery | 1 | 1996 | 41 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 1996 | 34 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1996 | 89 | 0.030 |
Why?
|
Hypoalbuminemia | 1 | 2015 | 27 | 0.030 |
Why?
|
Ligation | 2 | 1996 | 77 | 0.030 |
Why?
|
Cholic Acids | 1 | 1995 | 17 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2015 | 29 | 0.030 |
Why?
|
Polyamines | 1 | 1996 | 39 | 0.030 |
Why?
|
Phagocytes | 1 | 1996 | 90 | 0.030 |
Why?
|
Lipid Peroxides | 1 | 1995 | 8 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2016 | 299 | 0.030 |
Why?
|
Asphyxia | 1 | 1995 | 21 | 0.030 |
Why?
|
Crigler-Najjar Syndrome | 1 | 1995 | 2 | 0.030 |
Why?
|
Glycylglycine | 1 | 1995 | 2 | 0.030 |
Why?
|
Glucuronosyltransferase | 1 | 1995 | 10 | 0.030 |
Why?
|
Capsule Endoscopes | 1 | 2015 | 8 | 0.030 |
Why?
|
Cytokines | 3 | 2011 | 1852 | 0.030 |
Why?
|
Agglutinins | 1 | 1995 | 2 | 0.030 |
Why?
|
Cryoglobulins | 1 | 1995 | 7 | 0.030 |
Why?
|
Aged | 4 | 2001 | 19356 | 0.030 |
Why?
|
Coombs Test | 1 | 1995 | 5 | 0.030 |
Why?
|
Dietary Proteins | 2 | 1993 | 132 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 1996 | 86 | 0.030 |
Why?
|
Cryoglobulinemia | 1 | 1995 | 5 | 0.030 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 10 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1995 | 31 | 0.030 |
Why?
|
Disabled Persons | 1 | 1997 | 150 | 0.030 |
Why?
|
Vitamin K Deficiency | 1 | 1994 | 9 | 0.030 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
|
Calcium | 1 | 2001 | 1125 | 0.030 |
Why?
|
Ileum | 1 | 1995 | 100 | 0.030 |
Why?
|
Esophagoscopy | 1 | 1996 | 189 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1995 | 24 | 0.030 |
Why?
|
Rats, Mutant Strains | 1 | 1994 | 25 | 0.030 |
Why?
|
Permeability | 1 | 2015 | 153 | 0.030 |
Why?
|
Rats, Inbred WKY | 1 | 2014 | 37 | 0.030 |
Why?
|
Placebos | 1 | 2014 | 198 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 37 | 0.030 |
Why?
|
Hypobetalipoproteinemias | 2 | 1991 | 2 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 32 | 0.030 |
Why?
|
Iron | 1 | 1996 | 242 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2014 | 106 | 0.030 |
Why?
|
Breath Tests | 1 | 2014 | 88 | 0.030 |
Why?
|
Malondialdehyde | 2 | 1996 | 29 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 1996 | 240 | 0.030 |
Why?
|
Length of Stay | 1 | 1998 | 989 | 0.030 |
Why?
|
Health Promotion | 1 | 2000 | 687 | 0.030 |
Why?
|
Hyperbilirubinemia | 2 | 2005 | 16 | 0.030 |
Why?
|
Endoscopy | 1 | 1996 | 266 | 0.030 |
Why?
|
Genetic Variation | 1 | 2019 | 900 | 0.030 |
Why?
|
Cimetidine | 1 | 1993 | 16 | 0.030 |
Why?
|
Ranitidine | 1 | 1993 | 13 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 138 | 0.030 |
Why?
|
Hospitalization | 1 | 2022 | 1762 | 0.030 |
Why?
|
Kidney | 3 | 1995 | 1344 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2015 | 192 | 0.030 |
Why?
|
Dogs | 1 | 1994 | 356 | 0.030 |
Why?
|
Gastric Mucosa | 1 | 1993 | 44 | 0.030 |
Why?
|
Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1993 | 37 | 0.030 |
Why?
|
Lymph Nodes | 1 | 1996 | 430 | 0.030 |
Why?
|
Rectal Fistula | 1 | 2013 | 21 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2014 | 333 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 1993 | 34 | 0.030 |
Why?
|
Diuretics | 1 | 1993 | 75 | 0.030 |
Why?
|
Phototherapy | 1 | 1993 | 25 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2012 | 42 | 0.030 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 306 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 331 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 1996 | 239 | 0.030 |
Why?
|
False Negative Reactions | 2 | 1991 | 53 | 0.030 |
Why?
|
Salmonella Infections | 1 | 1993 | 51 | 0.030 |
Why?
|
Platelet Count | 1 | 2012 | 80 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2014 | 419 | 0.030 |
Why?
|
Social Behavior | 1 | 2015 | 273 | 0.030 |
Why?
|
Species Specificity | 1 | 2014 | 561 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 244 | 0.030 |
Why?
|
Amino Acid Sequence | 4 | 1998 | 2032 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 180 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 1233 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2007 | 97 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2014 | 204 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2012 | 294 | 0.030 |
Why?
|
Absorption | 2 | 1990 | 55 | 0.030 |
Why?
|
Documentation | 1 | 2013 | 170 | 0.030 |
Why?
|
Database Management Systems | 1 | 2012 | 49 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 1992 | 62 | 0.030 |
Why?
|
Trypsinogen | 1 | 1991 | 9 | 0.030 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.030 |
Why?
|
Diffuse Cerebral Sclerosis of Schilder | 1 | 1991 | 4 | 0.030 |
Why?
|
Diarrhea, Infantile | 1 | 1991 | 7 | 0.030 |
Why?
|
Connective Tissue | 1 | 2011 | 36 | 0.020 |
Why?
|
Drug Overdose | 1 | 1996 | 293 | 0.020 |
Why?
|
Vital Capacity | 1 | 2012 | 257 | 0.020 |
Why?
|
Sex Factors | 1 | 2017 | 1758 | 0.020 |
Why?
|
Electrolytes | 1 | 1991 | 59 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2012 | 109 | 0.020 |
Why?
|
Choledochostomy | 1 | 2011 | 14 | 0.020 |
Why?
|
Blood Bactericidal Activity | 1 | 2010 | 35 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 21 | 0.020 |
Why?
|
Uric Acid | 1 | 2014 | 349 | 0.020 |
Why?
|
Coproporphyrins | 1 | 1990 | 3 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1990 | 7 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 455 | 0.020 |
Why?
|
Cognition | 1 | 2018 | 988 | 0.020 |
Why?
|
Porphyrins | 1 | 1990 | 16 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2012 | 179 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 1990 | 74 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 130 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2012 | 517 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 400 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 55 | 0.020 |
Why?
|
Emotions | 1 | 2015 | 487 | 0.020 |
Why?
|
Asia | 1 | 1990 | 54 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 1992 | 567 | 0.020 |
Why?
|
Africa | 1 | 1990 | 97 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 1995 | 446 | 0.020 |
Why?
|
Hydroxycholecalciferols | 1 | 1989 | 3 | 0.020 |
Why?
|
Infant Nutrition Disorders | 1 | 1989 | 11 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 428 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1992 | 386 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2011 | 197 | 0.020 |
Why?
|
Carrier State | 1 | 1990 | 57 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 1990 | 94 | 0.020 |
Why?
|
Hemoglobin SC Disease | 1 | 1989 | 14 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2013 | 489 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 391 | 0.020 |
Why?
|
Body Height | 1 | 1990 | 187 | 0.020 |
Why?
|
Models, Statistical | 1 | 2013 | 627 | 0.020 |
Why?
|
Protozoan Infections | 1 | 1989 | 10 | 0.020 |
Why?
|
Hyaline Membrane Disease | 1 | 1989 | 20 | 0.020 |
Why?
|
Solubility | 1 | 1989 | 232 | 0.020 |
Why?
|
Colitis | 1 | 1991 | 219 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 1499 | 0.020 |
Why?
|
Nervous System | 1 | 1989 | 63 | 0.020 |
Why?
|
Mammalian orthoreovirus 3 | 1 | 1988 | 35 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 1172 | 0.020 |
Why?
|
Monocytes | 1 | 2011 | 507 | 0.020 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1989 | 50 | 0.020 |
Why?
|
Digestive System | 1 | 1988 | 28 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 1995 | 793 | 0.020 |
Why?
|
Rectum | 2 | 1991 | 152 | 0.020 |
Why?
|
Living Donors | 1 | 2011 | 325 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1992 | 1063 | 0.020 |
Why?
|
Hemophilia A | 1 | 1989 | 68 | 0.020 |
Why?
|
Gastroenteritis | 1 | 1989 | 64 | 0.020 |
Why?
|
Probability | 1 | 2008 | 296 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2010 | 750 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1989 | 156 | 0.020 |
Why?
|
Antigens, Viral | 1 | 1988 | 177 | 0.020 |
Why?
|
Heart Failure | 1 | 2000 | 1962 | 0.020 |
Why?
|
gamma-Tocopherol | 1 | 2007 | 4 | 0.020 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2007 | 25 | 0.020 |
Why?
|
Micelles | 1 | 2007 | 34 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1989 | 215 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 408 | 0.020 |
Why?
|
Oligoclonal Bands | 1 | 2007 | 21 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 2813 | 0.020 |
Why?
|
Biological Availability | 1 | 2007 | 125 | 0.020 |
Why?
|
Myoclonus | 1 | 1987 | 12 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 119 | 0.020 |
Why?
|
Cell Movement | 1 | 2011 | 877 | 0.020 |
Why?
|
Diet Surveys | 1 | 2007 | 84 | 0.020 |
Why?
|
Self Report | 1 | 2010 | 696 | 0.020 |
Why?
|
Liver Extracts | 1 | 2006 | 1 | 0.020 |
Why?
|
Chromans | 1 | 2006 | 20 | 0.020 |
Why?
|
Kinetics | 2 | 2005 | 1583 | 0.020 |
Why?
|
CD3 Complex | 1 | 2006 | 93 | 0.020 |
Why?
|
Propionates | 1 | 2006 | 34 | 0.020 |
Why?
|
Triglycerides | 3 | 1996 | 500 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 825 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1989 | 226 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2006 | 203 | 0.020 |
Why?
|
Pancreatic Extracts | 1 | 1985 | 2 | 0.020 |
Why?
|
Tablets, Enteric-Coated | 1 | 1985 | 4 | 0.020 |
Why?
|
Reflex, Abnormal | 1 | 1985 | 7 | 0.020 |
Why?
|
Biliary Tract | 1 | 2005 | 16 | 0.020 |
Why?
|
Mice, SCID | 1 | 2006 | 328 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2005 | 21 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2014 | 1162 | 0.020 |
Why?
|
Neoplasms | 1 | 2009 | 2146 | 0.020 |
Why?
|
Autopsy | 1 | 2005 | 86 | 0.020 |
Why?
|
Muscles | 1 | 1987 | 328 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2003 | 798 | 0.020 |
Why?
|
United Kingdom | 1 | 2006 | 233 | 0.020 |
Why?
|
Amylopectin | 1 | 2005 | 5 | 0.020 |
Why?
|
Lipase | 1 | 1985 | 67 | 0.020 |
Why?
|
Sputum | 1 | 2007 | 289 | 0.020 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2007 | 133 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2005 | 90 | 0.020 |
Why?
|
HLA Antigens | 1 | 2006 | 220 | 0.020 |
Why?
|
Glycocholic Acid | 1 | 1985 | 6 | 0.020 |
Why?
|
Cell Membrane | 1 | 1989 | 681 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1987 | 223 | 0.020 |
Why?
|
Blood Glucose | 1 | 2014 | 1931 | 0.020 |
Why?
|
Perioperative Care | 1 | 2006 | 129 | 0.020 |
Why?
|
Sigmoidoscopy | 1 | 1984 | 10 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 160 | 0.020 |
Why?
|
Nasal Septum | 1 | 1984 | 17 | 0.020 |
Why?
|
Portal System | 1 | 2004 | 14 | 0.020 |
Why?
|
Insulin | 1 | 2014 | 2135 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2006 | 253 | 0.020 |
Why?
|
Nasopharynx | 1 | 1984 | 62 | 0.010 |
Why?
|
Lung Diseases | 1 | 1991 | 693 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 1984 | 81 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 2004 | 32 | 0.010 |
Why?
|
Needs Assessment | 1 | 2006 | 320 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1984 | 218 | 0.010 |
Why?
|
Neurologic Manifestations | 1 | 1983 | 3 | 0.010 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2003 | 23 | 0.010 |
Why?
|
Reye Syndrome | 1 | 1983 | 4 | 0.010 |
Why?
|
Autoantigens | 1 | 2006 | 397 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 2003 | 56 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1983 | 78 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1983 | 117 | 0.010 |
Why?
|
Health | 1 | 2003 | 79 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 682 | 0.010 |
Why?
|
Hepatic Artery | 1 | 1983 | 52 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2004 | 173 | 0.010 |
Why?
|
Vomiting | 1 | 1983 | 123 | 0.010 |
Why?
|
Biological Transport | 1 | 1983 | 378 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2003 | 223 | 0.010 |
Why?
|
Chickenpox | 1 | 1983 | 95 | 0.010 |
Why?
|
Giardiasis | 1 | 1982 | 14 | 0.010 |
Why?
|
Electrocardiography | 1 | 2005 | 548 | 0.010 |
Why?
|
Intellectual Disability | 1 | 1983 | 132 | 0.010 |
Why?
|
Chylomicrons | 2 | 1993 | 6 | 0.010 |
Why?
|
Spine | 1 | 1983 | 141 | 0.010 |
Why?
|
Succinate Cytochrome c Oxidoreductase | 1 | 2001 | 2 | 0.010 |
Why?
|
NADH Dehydrogenase | 1 | 2001 | 18 | 0.010 |
Why?
|
Fingers | 1 | 1982 | 80 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 60 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2005 | 366 | 0.010 |
Why?
|
Citrate (si)-Synthase | 1 | 2001 | 49 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 1405 | 0.010 |
Why?
|
Hand | 1 | 1982 | 135 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 2000 | 162 | 0.010 |
Why?
|
Physical Examination | 1 | 2002 | 226 | 0.010 |
Why?
|
Face | 1 | 1982 | 166 | 0.010 |
Why?
|
Erysipelas | 1 | 1980 | 1 | 0.010 |
Why?
|
Ampicillin | 1 | 1980 | 13 | 0.010 |
Why?
|
Methicillin | 1 | 1980 | 12 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 563 | 0.010 |
Why?
|
Amoxicillin | 1 | 1980 | 20 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 940 | 0.010 |
Why?
|
Haemophilus influenzae | 1 | 1980 | 49 | 0.010 |
Why?
|
Skin | 1 | 1984 | 655 | 0.010 |
Why?
|
Gene Deletion | 1 | 2001 | 356 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 1983 | 328 | 0.010 |
Why?
|
Cytochrome P450 Family 7 | 1 | 1998 | 1 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 1588 | 0.010 |
Why?
|
CHO Cells | 1 | 1998 | 142 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 131 | 0.010 |
Why?
|
Cricetinae | 1 | 1998 | 259 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 263 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1998 | 168 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2005 | 2818 | 0.010 |
Why?
|
Multigene Family | 1 | 1998 | 198 | 0.010 |
Why?
|
Comorbidity | 1 | 2002 | 1487 | 0.010 |
Why?
|
Esophagoscopes | 1 | 1996 | 4 | 0.010 |
Why?
|
Apolipoprotein B-100 | 1 | 1996 | 8 | 0.010 |
Why?
|
Autoradiography | 1 | 1996 | 72 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 34 | 0.010 |
Why?
|
Microsomes | 1 | 1996 | 24 | 0.010 |
Why?
|
Endoscopes | 1 | 1996 | 18 | 0.010 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 1996 | 17 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1996 | 259 | 0.010 |
Why?
|
Adenine Nucleotides | 1 | 1995 | 20 | 0.010 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 1995 | 24 | 0.010 |
Why?
|
Adenomatous Polyposis Coli | 1 | 1995 | 31 | 0.010 |
Why?
|
Ulcer | 1 | 1995 | 28 | 0.010 |
Why?
|
Sicily | 1 | 1995 | 1 | 0.010 |
Why?
|
Africa, Northern | 1 | 1995 | 4 | 0.010 |
Why?
|
Genomic Library | 1 | 1995 | 14 | 0.010 |
Why?
|
France | 1 | 1995 | 35 | 0.010 |
Why?
|
Denmark | 1 | 1995 | 40 | 0.010 |
Why?
|
Hypoglycemia | 1 | 1999 | 402 | 0.010 |
Why?
|
England | 1 | 1995 | 69 | 0.010 |
Why?
|
Germany | 1 | 1995 | 89 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1995 | 99 | 0.010 |
Why?
|
Diarrhea | 1 | 1995 | 176 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1995 | 219 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1995 | 362 | 0.010 |
Why?
|
Fever | 1 | 1995 | 281 | 0.010 |
Why?
|
Epitopes | 1 | 1996 | 436 | 0.010 |
Why?
|
Exons | 1 | 1995 | 302 | 0.010 |
Why?
|
Isoenzymes | 1 | 1995 | 293 | 0.010 |
Why?
|
DNA Primers | 1 | 1995 | 525 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1995 | 498 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1998 | 436 | 0.010 |
Why?
|
Lipoproteins, VLDL | 1 | 1993 | 20 | 0.010 |
Why?
|
Acetaminophen | 1 | 1995 | 243 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1993 | 83 | 0.010 |
Why?
|
Deuterium | 1 | 1993 | 77 | 0.010 |
Why?
|
Sheep | 1 | 1995 | 763 | 0.010 |
Why?
|
Transfection | 1 | 1995 | 877 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1993 | 131 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 967 | 0.010 |
Why?
|
Blood Urea Nitrogen | 1 | 1992 | 58 | 0.010 |
Why?
|
Synapses | 1 | 1995 | 340 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 66 | 0.010 |
Why?
|
Sweat | 1 | 1991 | 38 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1991 | 70 | 0.010 |
Why?
|
Sulfasalazine | 1 | 1991 | 21 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1991 | 79 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1991 | 112 | 0.010 |
Why?
|
Carbohydrate Metabolism | 1 | 1991 | 50 | 0.010 |
Why?
|
Status Epilepticus | 1 | 1991 | 35 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1991 | 66 | 0.010 |
Why?
|
Isomerism | 1 | 1990 | 43 | 0.010 |
Why?
|
Heterozygote | 1 | 1991 | 256 | 0.010 |
Why?
|
Colorimetry | 1 | 1990 | 14 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1991 | 524 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1991 | 232 | 0.010 |
Why?
|
Respiration | 1 | 1991 | 182 | 0.010 |
Why?
|
RNA Splicing | 1 | 1991 | 244 | 0.010 |
Why?
|
Energy Intake | 1 | 1992 | 427 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1991 | 523 | 0.010 |
Why?
|
Birth Weight | 1 | 1992 | 466 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 1327 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 1989 | 44 | 0.010 |
Why?
|
Breast Feeding | 1 | 1992 | 383 | 0.010 |
Why?
|
Phospholipids | 1 | 1990 | 202 | 0.010 |
Why?
|
Alleles | 1 | 1991 | 816 | 0.010 |
Why?
|
Fats | 1 | 1987 | 13 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1987 | 582 | 0.000 |
Why?
|